http://www.mmm-online.com/untitled-letter/topic/8454/ Articles tagged with Untitled Letter from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no Aveo CRL says company's kidney drug information is uninterpretable; Dynavax has to find more hepatitis B clinical trial patients; Gilead's hep C drug gets priority status; OPDP slaps Janssen and Sigma Tau with untitled letters. http://www.mmm-online.com/business-briefs-aveo-dynavax-gilead-opdp/article/297144/ Mon, 10 Jun 2013 18:01:16 GMT Aveo CRL says company's kidney drug information is uninterpretable; Dynavax has to find more hepatitis B clinical trial patients; Gilead's hep C drug gets priority status; OPDP slaps Janssen and Sigma Tau with untitled letters. MMM The FDA has issued a rare untitled letter concerning a pitch letter - a reminder that the agency does not consider press materials to be exempted from its oversight. http://www.mmm-online.com/with-untitled-letter-fda-signals-press-materials-arent-exempt/article/269255/ Tue, 20 Nov 2012 19:37:35 GMT The FDA has issued a rare untitled letter concerning a pitch letter - a reminder that the agency does not consider press materials to be exempted from its oversight. MMM The drug industry may be settling in for a hot, lazy summer, but FDA's Office of Prescription Drug Promotion has been keeping busy, issuing untitled letters to Pfizer, Valeant and Acorda Therapeutics over allegedly violative promotions in recent weeks. http://www.mmm-online.com/pfizer-valeant-and-acorda-hit-with-untitled-letters/article/249670/ Tue, 10 Jul 2012 18:52:23 GMT The drug industry may be settling in for a hot, lazy summer, but FDA's Office of Prescription Drug Promotion has been keeping busy, issuing untitled letters to Pfizer, Valeant and Acorda Therapeutics over allegedly violative promotions in recent weeks. MMM The FDA's Office of Prescription Drug Promotion served Sobi and Watson with untitled letters. http://www.mmm-online.com/sobi-watson-get-opdp-untitled-letters/article/248173/ Fri, 29 Jun 2012 18:15:15 GMT The FDA's Office of Prescription Drug Promotion served Sobi and Watson with untitled letters. MMM Pfizer's Lipitor website touted the efficacy of Caduet, Chantix and Norvasc but failed to balance those claims with risk info for the drugs, according to an "untitled letter" from FDA's Division of Drug Marketing, Advertising and Communication (DDMAC). http://www.mmm-online.com/lipitorcom-gets-bad-ad-slap-for-cross-promotion-sans-risk-info/article/211332/ Tue, 06 Sep 2011 19:38:55 GMT Pfizer's Lipitor website touted the efficacy of Caduet, Chantix and Norvasc but failed to balance those claims with risk info for the drugs, according to an "untitled letter" from FDA's Division of Drug Marketing, Advertising and Communication (DDMAC). MMM A print ad for Genentech's Boniva overstated the osteoporosis drug's efficacy, said the FDA's Division of Drug Marketing, Advertising and Communication in an untitled letter. http://www.mmm-online.com/boniva-print-ad-hyped-efficacy-says-ddmac/article/195058/ Wed, 26 Jan 2011 19:53:25 GMT A print ad for Genentech's Boniva overstated the osteoporosis drug's efficacy, said the FDA's Division of Drug Marketing, Advertising and Communication in an untitled letter. MMM The FDA's Division of Drug Marketing, Advertising and Communications has written 26% more enforcement letters to drug companies over promotional practices this year than it did in 2009. http://www.mmm-online.com/ddmac-enforcement-letters-up-26-in-2010/article/193399/ Tue, 28 Dec 2010 20:43:38 GMT The FDA's Division of Drug Marketing, Advertising and Communications has written 26% more enforcement letters to drug companies over promotional practices this year than it did in 2009. MMM Allergan has a superiority complex when it comes to marketing its ophthalmic drops, as evidenced by a second DDMAC Untitled Letter posted online yesterday. http://www.mmm-online.com/ddmac-pokes-allergan-on-eye-drop-direct-mail/article/192328/ Tue, 07 Dec 2010 17:26:54 GMT Allergan has a superiority complex when it comes to marketing its ophthalmic drops, as evidenced by a second DDMAC Untitled Letter posted online yesterday. MMM A convention graphic for Alcon's Travatan Z, an ophthalmic drop, broadened the product's indication and made unsubstantiated superiority claims, according to a Division of Drug Marketing, Advertising and Communications (DDMAC) Untitled Letter. http://www.mmm-online.com/ddmac-slaps-alcon-convention-graphic/article/181764/ Tue, 26 Oct 2010 17:07:34 GMT A convention graphic for Alcon's Travatan Z, an ophthalmic drop, broadened the product's indication and made unsubstantiated superiority claims, according to a Division of Drug Marketing, Advertising and Communications (DDMAC) Untitled Letter. MMM Patient testimonial videos on the brand.com homepage for Wyeth's (now Pfizer's) Premarin overstated the drug's efficacy and minimized risks, while a journal ad for Allergan's Acuvail made unsubstantiated superiority claims, overstated efficacy, broadened the drug's indication, and omitted risk information, according to a pair of untitled DDMAC letters. http://www.mmm-online.com/ddmac-slaps-premarin-patient-testimonials-acuvail-journal-ad/article/178881/ Tue, 14 Sep 2010 19:12:17 GMT Patient testimonial videos on the brand.com homepage for Wyeth's (now Pfizer's) Premarin overstated the drug's efficacy and minimized risks, while a journal ad for Allergan's Acuvail made unsubstantiated superiority claims, overstated efficacy, broadened the drug's indication, and omitted risk information, according to a pair of untitled DDMAC letters. MMM